Investing in Business – not Science 

We believe innovation and cost reduction within the healthcare sector are creating opportunities for the best companies to gain share and generate strong returns. Through our disciplined investment process, we focus on profitability and reinvestment to access return potential.

Focus on business not science

Rather than trying to predict scientific outcomes, we use in-depth research and analysis to invest in businesses that aim to provide better outcomes, help to drive cost savings and generate profits.

High quality business

Through continuous collaboration between managers and analysts, we select between 40-60 stocks,  investing in what we believe to be the very best businesses. We look for capital efficiency and strong reinvestment rates to achieve quality compounding. 

Risk management

The healthcare sector has defensive characteristics and is less exposed to the macro environment. Portfolio risk is balanced around multiple companies, as opposed to only a few stocks delivering extreme individual performance.

The value of an investment can go down as well as up and investors may not get back the full amount they invested. Capital is at risk.

An Experienced Team

Our portfolio managers are supported by a dedicated team of analysts and researchers offering deep experience and global perspectives. 


Investment Risks to Consider

These and other risks are described in the Portfolio's prospectus

Investment in the Portfolio entails certain risks. Investment returns and principal value of the Portfolio will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Some of the principal risks of investing in the Portfolio include:

  • Allocation risk: The risk that the allocation of investments between growth and value companies may have a more significant effect on the Portfolio’s Net Asset Value (NAV) when one of these strategies is not performing as well as the other. In addition, the transaction costs of rebalancing the investments may, over time, be significant.

  • Derivatives risk: The Portfolio may include financial derivative instruments. These may be used to obtain, increase or reduce exposure to underlying assets and may create gearing; their use may result in greater fluctuations of the net asset value.

  • Emerging-markets risk: Where the Portfolio invests in emerging markets, these assets are generally smaller and more sensitive to economic and political factors, and may be less easily traded, which could cause a loss to the Portfolio.

  • Equity securities risk: The value of equity investments may fluctuate in response to the activities and results of individual companies or because of market and economic conditions. These investments may decline over short- or long-term periods.

  • Focused portfolio risk: Investing in a limited number of issuers, industries, sectors or countries may subject the Portfolio to greater volatility than one invested in a larger or more diverse array of securities.

  • OTC derivatives counterparty risk: Transactions in over-the-counter (OTC) derivatives markets may have generally less governmental regulation and supervision than transactions entered into on organized exchanges. These will be subject to the risk that its direct counterparty will not perform its obligations and that the Portfolio will sustain losses.

  • Portfolio turnover risk: A portfolio may be actively managed and turnover may, in response to market conditions, exceed 100%. A higher rate of portfolio turnover increases brokerage and other expenses. High portfolio turnover may also result in the realization of substantial net short-term capital gains, which may be taxable when distributed.



Fund Literature